The Neurobiological Effect of 5-HT2AR Modulation
Clinical trial NCT03289949 · RECRUITING
Trial details
- NCT number
- NCT03289949
- Sponsor
- Gitte Moos Knudsen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2030-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.